Univariate analyses showed that ORRs were consistent across key covariates, including disease stage, high-risk cytogenetic profile, extramedullary disease, baseline tumor burden, BCMA expression, CD19 detection, number of previous therapy lines, and time since diagnosis. Here, CD19 is linked to neoplasm.